Literature DB >> 16842964

Neuropathic agents and pain. New strategies.

M S Chong1, B Brandner.   

Abstract

At present, the opioids, anti-epileptic, membrane stabilising and anti-depressant drugs are the mainstay of treatment for alleviating neuropathic pain. This article summarises data on some new medications of these classes and also other groups of medications in development. Recent data on the use of combination medications and its implications will also be discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16842964     DOI: 10.1016/j.biopha.2006.06.016

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  6 in total

Review 1.  The use of non-narcotic pain medication in pediatric gastroenterology.

Authors:  Adrian Miranda; Miguel Saps
Journal:  Paediatr Drugs       Date:  2014-08       Impact factor: 3.022

2.  Population pharmacokinetic model of the pregabalin-sildenafil interaction in rats: application of simulation to preclinical PK-PD study design.

Authors:  Gregor Bender; James Gosset; Jeff Florian; Keith Tan; Mark Field; Scott Marshall; Joost DeJongh; Robert Bies; Meindert Danhof
Journal:  Pharm Res       Date:  2009-08-11       Impact factor: 4.200

3.  Prevalence and treatment of depression in children and adolescents with sickle cell disease: a retrospective cohort study.

Authors:  Jeanette M Jerrell; Avnish Tripathi; Roger S McIntyre
Journal:  Prim Care Companion CNS Disord       Date:  2011

4.  Pain, pain, go away: antidepressants and pain management.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2008-12

5.  Effect of glibenclamide on antinociceptive effects of antidepressants of different classes.

Authors:  Valiollah Hajhashemi; Bahareh Amin
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

6.  Design, synthesis and biological activity evaluation of arylpiperazine derivatives for the treatment of neuropathic pain.

Authors:  Yin Chen; Guan Wang; Xiangqing Xu; Bi-Feng Liu; Jianqi Li; Guisen Zhang
Journal:  Molecules       Date:  2011-07-07       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.